These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11422738)

  • 1. Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals.
    Hoyer JR; Asplin JR; Otvos L
    Kidney Int; 2001 Jul; 60(1):77-82. PubMed ID: 11422738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals.
    O'Young J; Chirico S; Al Tarhuni N; Grohe B; Karttunen M; Goldberg HA; Hunter GK
    Cells Tissues Organs; 2009; 189(1-4):51-5. PubMed ID: 18728346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of calcium oxalate crystal growth by face-specific adsorption of an osteopontin phosphopeptide.
    Grohe B; O'Young J; Ionescu DA; Lajoie G; Rogers KA; Karttunen M; Goldberg HA; Hunter GK
    J Am Chem Soc; 2007 Dec; 129(48):14946-51. PubMed ID: 17994739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of osteopontin peptide into kidney stone-related calcium oxalate monohydrate crystals: a quantitative study.
    Gleberzon JS; Liao Y; Mittler S; Goldberg HA; Grohe B
    Urolithiasis; 2019 Oct; 47(5):425-440. PubMed ID: 30569197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of human uropontin to inhibition of calcium oxalate crystallization.
    Asplin JR; Arsenault D; Parks JH; Coe FL; Hoyer JR
    Kidney Int; 1998 Jan; 53(1):194-9. PubMed ID: 9453018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of osteopontin is required for inhibition of calcium oxalate crystallization.
    Wang L; Guan X; Tang R; Hoyer JR; Wierzbicki A; De Yoreo JJ; Nancollas GH
    J Phys Chem B; 2008 Jul; 112(30):9151-7. PubMed ID: 18611047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring calcium oxalate crystallization: a constant composition approach.
    Kolbach-Mandel AM; Kleinman JG; Wesson JA
    Urolithiasis; 2015 Oct; 43(5):397-409. PubMed ID: 26016572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of calcium oxalate crystallization by linear aspartic acid-rich peptides.
    Wang L; Qiu SR; Zachowicz W; Guan X; Deyoreo JJ; Nancollas GH; Hoyer JR
    Langmuir; 2006 Aug; 22(17):7279-85. PubMed ID: 16893227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of calcium oxalate crystal growth in the presence of osteopontin isoforms: an analysis by scanning confocal interference microcopy.
    Langdon A; Wignall GR; Rogers K; Sørensen ES; Denstedt J; Grohe B; Goldberg HA; Hunter GK
    Calcif Tissue Int; 2009 Mar; 84(3):240-8. PubMed ID: 19189038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the catalysis of calcium oxalate dihydrate formation by osteopontin peptides.
    Chan BP; Vincent K; Lajoie GA; Goldberg HA; Grohe B; Hunter GK
    Colloids Surf B Biointerfaces; 2012 Aug; 96():22-8. PubMed ID: 22503630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals.
    Taller A; Grohe B; Rogers KA; Goldberg HA; Hunter GK
    Biophys J; 2007 Sep; 93(5):1768-77. PubMed ID: 17496021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of urinary macromolecules with calcium oxalate crystals induced in vitro in normal human and rat urine.
    Atmani F; Opalko FJ; Khan SR
    Urol Res; 1996; 24(1):45-50. PubMed ID: 8966841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modulation of calcium oxalate crystallization.
    De Yoreo JJ; Qiu SR; Hoyer JR
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1123-31. PubMed ID: 17082348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of phosphate groups in inhibition of calcium oxalate crystal growth by osteopontin.
    Hunter GK; Grohe B; Jeffrey S; O'Young J; Sørensen ES; Goldberg HA
    Cells Tissues Organs; 2009; 189(1-4):44-50. PubMed ID: 18703867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of osteopontin on calcium oxalate crystal formation.
    Konya E; Umekawa T; Iguchi M; Kurita T
    Eur Urol; 2003 May; 43(5):564-71. PubMed ID: 12706004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effects of fibronectin on calcium oxalate crystallization, growth, aggregation, adhesion on renal tubular cells, and invasion through extracellular matrix.
    Khamchun S; Sueksakit K; Chaiyarit S; Thongboonkerd V
    J Biol Inorg Chem; 2019 Mar; 24(2):235-246. PubMed ID: 30701361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of urine fractionation on attachment of calcium oxalate crystals to renal epithelial cells: implications for studying renal calculogenesis.
    Grover PK; Thurgood LA; Ryall RL
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1396-403. PubMed ID: 17267387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
    Kumar V; Farell G; Lieske JC
    J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin.
    Worcester EM; Blumenthal SS; Beshensky AM; Lewand DL
    J Bone Miner Res; 1992 Sep; 7(9):1029-36. PubMed ID: 1414495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.